In this review:
Tacrolimus as secondline treatment for chronic autoimmune hepatitis
Severe acute HCV exacerbation in cancer patients receiving chemotherapy
Direct-acting antivirals in HCV-related HCC
Concurrent HBsAg and HBV surface antibody
Renal safety of tenofovir disoproxil fumarate and entecavir
IL-22 agonist F-652 for alcohol-associated hepatitis
Towards a single-visit cure for chronic HCV
Modifiable comorbidities in HCV patients
HCV testing among people who inject drugs
Please login below to download this issue (PDF)